JRP
VIRX
Jasper Ridge Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-92,939
| Closed | -$148K | – | 151 |
|
|
2023
Q1 | $148K | Hold |
92,939
| – | – | 0.01% | 137 |
|
|
2022
Q4 | $136K | Hold |
92,939
| – | – | 0.01% | 131 |
|
|
2022
Q3 | $397K | Hold |
92,939
| – | – | 0.03% | 106 |
|
|
2022
Q2 | $361K | Hold |
92,939
| – | – | 0.02% | 112 |
|
|
2022
Q1 | $442K | Hold |
92,939
| – | – | 0.02% | 116 |
|
|
2021
Q4 | $339K | Hold |
92,939
| – | – | 0.01% | 132 |
|
|
2021
Q3 | $745K | Buy |
+92,939
| New | +$745K | 0.03% | 112 |
|